Current developments in the health sector include Novo Nordisk's warning about counterfeit Ozempic in the US, Sandoz's antitrust lawsuit against Amgen, and rising concerns in the biotech industry due ...

The FDA says it was notified by Novo Nordisk on April 3 that several hundred units of counterfeit Ozempic (semaglutide) ...

The maker of Ozempic and the weight loss drug Wegovy told the FDA on April 3 that counterfeit 1-milligram injections were ...

Shares of China's Duality Biotherapeutics were set to rise 91.3% in their Hong Kong debut on Tuesday after the company raised $213 million in an initial public offering launched as financial markets ...

The FDA and Novo Nordisk are warning of counterfeit Ozempic® (semaglutide) which could pose a safety risk. The FDA and ...

The Food and Drug Administration says it has seized several hundred units of fake versions of Ozempic. The drug maker Novo ...

The U.S. Food and Drug Administration on Monday warned consumers and pharmacies that fake versions of Ozempic, a drug to ...

The drug manufacturer will no longer study and test danuglipron after a participant in a clinical trial was injured.

The health sector faces numerous challenges, including counterfeit Ozempic, a Sandoz antitrust lawsuit against Amgen, Trump's ...

Novo Nordisk notified the Food and Drug Administration about several hundred units of fake semaglutide 1.0 mg in the US drug supply chain.

The maker of Ozempic and federal regulators are sending out warnings about counterfeit versions of the anti-diabetic drug ...

The maker of Ozempic and federal regulators are sending out warnings about counterfeit versions of the anti-diabetic drug ...